Overview
Hezhen Wu practices practicing medicine in Wuhan, China.
Their clinical expertise encompasses Chronic Graft Versus Host Disease (cGvHD), Lung Adenocarcinoma, Liver Cancer, and Colorectal Cancer.
They are actively involved in clinical research, co-authoring 31 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Hezhen Wu
Is Hezhen Wu a top-rated expert for Chronic Graft Versus Host Disease (cGvHD)?
MediFind is an objective health platform that identifies experts based on real-world data. Hezhen Wu is classified as an Experienced expert for Chronic Graft Versus Host Disease (cGvHD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Hezhen Wu participate in research or clinical trials?
Yes. Hezhen Wu has published 31 articles and abstracts on conditions like Chronic Graft Versus Host Disease (cGvHD). You can view a list of Hezhen Wu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Chronic Graft Versus Host Disease (cGvHD)
- Colorectal CancerWu isExperienced. Learn about Colorectal Cancer.
- Liver CancerWu isExperienced. Learn about Liver Cancer.
- Lung AdenocarcinomaWu isExperienced. Learn about Lung Adenocarcinoma.